The Efficacy and Tolerability of Turmeric and Salicylic Acid in Psoriasis Treatment

Z. Draelos
{"title":"The Efficacy and Tolerability of Turmeric and Salicylic Acid in Psoriasis Treatment","authors":"Z. Draelos","doi":"10.2147/PTT.S360448","DOIUrl":null,"url":null,"abstract":"Introduction This study examined the efficacy and tolerability of a once-daily regimen of a 3% salicylic acid treatment gel containing turmeric and a low concentration of salicylic acid plus shea butter exfoliating moisturizer when used as monotherapy or in as an adjunct to other Rx psoriasis medications. Patients and Methods This single-site 12-week study enrolled 20 subjects >18 years of age with mild-to-moderate psoriasis involving <10% body surface area. Assessments were performed at baseline and Weeks 4, 8, and 12 using a 5-point scale (0 = none to 4 = severe). The investigator-assessed efficacy (changes from baseline for erythema, desquamation, induration, and overall global assessment [IGA]) and tolerability (irritation and edema). Study subjects assessed efficacy parameters of redness, scaling, and overall skin problems along with tolerability parameters of stinging, burning, itching, and irritation. Subjects applied the turmeric and salicylic acid treatment gel along with a moisturizer once daily to all affected areas. Results Half (50%) of the subjects were using concomitant Rx psoriasis treatments, while the other 50% received the study psoriasis treatment regimen as monotherapy. Investigator assessments of erythema, desquamation, induration, and IGA scores showed significant reductions from baseline (P ≤ 0.021) at Weeks 4, 8, and 12. At Week 12, these reductions reached 48%, 46%, 51%, and 48%, for these parameters, respectively. The investigator observed no irritation or edema at any time point. Subject assessments of redness, scaling, and overall improvement demonstrated significant reductions in 8 of 9 assessments (P ≤ 0.037). The subjects reported mild irritation at Weeks 4, 8, and 12. No treatment compliance issues or adverse events related to study product occurred during the study. Conclusion A once-daily over-the-counter (OTC) turmeric/salicylic acid gel followed by a shea butter/salicylic acid exfoliating moisturizer demonstrated excellent tolerability and efficacy in plaque-type psoriasis after 12 weeks of once-daily use.","PeriodicalId":20796,"journal":{"name":"Psoriasis : Targets and Therapy","volume":"9 1","pages":"63 - 71"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psoriasis : Targets and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/PTT.S360448","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction This study examined the efficacy and tolerability of a once-daily regimen of a 3% salicylic acid treatment gel containing turmeric and a low concentration of salicylic acid plus shea butter exfoliating moisturizer when used as monotherapy or in as an adjunct to other Rx psoriasis medications. Patients and Methods This single-site 12-week study enrolled 20 subjects >18 years of age with mild-to-moderate psoriasis involving <10% body surface area. Assessments were performed at baseline and Weeks 4, 8, and 12 using a 5-point scale (0 = none to 4 = severe). The investigator-assessed efficacy (changes from baseline for erythema, desquamation, induration, and overall global assessment [IGA]) and tolerability (irritation and edema). Study subjects assessed efficacy parameters of redness, scaling, and overall skin problems along with tolerability parameters of stinging, burning, itching, and irritation. Subjects applied the turmeric and salicylic acid treatment gel along with a moisturizer once daily to all affected areas. Results Half (50%) of the subjects were using concomitant Rx psoriasis treatments, while the other 50% received the study psoriasis treatment regimen as monotherapy. Investigator assessments of erythema, desquamation, induration, and IGA scores showed significant reductions from baseline (P ≤ 0.021) at Weeks 4, 8, and 12. At Week 12, these reductions reached 48%, 46%, 51%, and 48%, for these parameters, respectively. The investigator observed no irritation or edema at any time point. Subject assessments of redness, scaling, and overall improvement demonstrated significant reductions in 8 of 9 assessments (P ≤ 0.037). The subjects reported mild irritation at Weeks 4, 8, and 12. No treatment compliance issues or adverse events related to study product occurred during the study. Conclusion A once-daily over-the-counter (OTC) turmeric/salicylic acid gel followed by a shea butter/salicylic acid exfoliating moisturizer demonstrated excellent tolerability and efficacy in plaque-type psoriasis after 12 weeks of once-daily use.
姜黄与水杨酸治疗银屑病的疗效及耐受性
本研究检测了每日一次的含有姜黄和低浓度水杨酸的3%水杨酸治疗凝胶加上乳木果去角质保湿剂作为单一疗法或作为其他Rx牛皮癣药物的辅助疗法的疗效和耐受性。患者和方法这项为期12周的单中心研究招募了20名年龄>18岁的轻至中度牛皮癣患者,患者的体表面积<10%。在基线和第4、8和12周采用5分制进行评估(0 =无至4 =严重)。研究者评估了疗效(红斑、脱屑、硬结和总体评估[IGA]的基线变化)和耐受性(刺激和水肿)。研究对象评估了发红、结垢和整体皮肤问题的疗效参数,以及刺痛、灼烧、瘙痒和刺激的耐受性参数。受试者将姜黄和水杨酸治疗凝胶连同润肤霜涂抹在所有受影响的部位,每天一次。结果一半(50%)的受试者同时使用Rx治疗银屑病,而另外50%的受试者接受研究银屑病治疗方案作为单一治疗。研究者对红斑、脱屑、硬结和IGA评分的评估显示,在第4、8和12周时,红斑、脱屑、硬结和IGA评分较基线显著降低(P≤0.021)。在第12周,这些参数分别降低了48%、46%、51%和48%。研究者在任何时间点均未观察到刺激或水肿。受试者对发红、结垢和整体改善的评估显示,9项评估中有8项显著降低(P≤0.037)。受试者在第4、8和12周报告轻度刺激。研究期间未发生与研究产品相关的治疗依从性问题或不良事件。结论:每日一次的非处方(OTC)姜黄/水杨酸凝胶和乳木果油/水杨酸去角质保湿霜在每日一次使用12周后,对斑块型银屑病表现出良好的耐受性和疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信